IBIO, INC. Earnings Per Share (Basic)
IBIO, INC. (IBIO) reported Earnings Per Share (Basic) of -$0.32 per share for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-28
- IBIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.07.
- IBIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- IBIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.09.
- IBIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.11.
- IBIO, INC. earnings per share, basic for fiscal 2026 was -$0.32.
- IBIO, INC. earnings per share, basic for fiscal 2025 was -$1.75.
- IBIO, INC. earnings per share, basic for fiscal 2024 was -$6.50.
- IBIO, INC. earnings per share, basic for fiscal 2023 was -$106.19.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.32 10-K · filed 2026-08-28 | ||||
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-12 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$0.25 10-Q · filed 2026-05-12 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-12-31 | -$0.09 10-Q · filed 2026-02-10 | -$0.19 10-Q · filed 2026-02-10 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-09-30 | -$0.11 10-Q/A · filed 2025-11-17 | -$0.32 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.61 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.93 derived: net income ÷ weighted average shares · filed 2026-08-28 | ||||
| 2025-06-30 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.29 derived: net income ÷ weighted average shares · filed 2026-08-28 | -$1.75 10-K · filed 2026-08-28 | ||||
| 2025-03-31 | -$0.49 10-Q · filed 2026-05-12 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-05-12 | -$1.44 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | -$0.48 10-Q · filed 2026-02-10 | -$0.94 10-Q · filed 2026-02-10 | ||||||
| 2024-09-30 | -$0.46 10-Q/A · filed 2025-11-17 | |||||||
| 2024-06-30 | -$6.50 10-K · filed 2025-09-05 | |||||||
| 2024-03-31 | -$0.85 10-Q · filed 2025-05-02 | -$7.62 10-Q · filed 2025-05-02 | ||||||
| 2023-12-31 | -$4.42 10-Q · filed 2025-02-10 | -$9.15 10-Q · filed 2025-02-10 | ||||||
| 2023-09-30 | -$4.80 10-Q · filed 2024-11-12 | -$0.24 10-Q · filed 2023-11-14 | -$9.73 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$17.99 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$33.51 derived: net income ÷ weighted average shares · filed 2024-11-12 | |||
| 2023-06-30 | -$5.75 derived: net income ÷ weighted average shares · filed 2024-09-24 | -$14.78 derived: net income ÷ weighted average shares · filed 2024-09-24 | -$32.55 derived: net income ÷ weighted average shares · filed 2024-09-24 | -$106.19 10-K/A · filed 2024-09-24 | -$5.31 10-K · filed 2023-09-27 | |||
| 2023-03-31 | -$11.07 10-Q · filed 2024-05-13 | -$0.55 10-Q · filed 2023-05-15 | -$29.32 derived: net income ÷ weighted average shares · filed 2024-05-13 | -$111.28 10-Q · filed 2024-05-13 | -$5.57 10-Q · filed 2023-05-15 | -$7.43 derived: net income ÷ weighted average shares · filed 2024-05-13 | ||
| 2022-12-31 | -$68.43 10-Q · filed 2024-02-09 | -$3.42 10-Q · filed 2023-02-14 | -$110.85 10-Q · filed 2024-02-09 | -$5.54 10-Q · filed 2023-02-14 | -$4.73 derived: net income ÷ weighted average shares · filed 2024-02-09 | -$5.26 derived: net income ÷ weighted average shares · filed 2024-02-09 | ||
| 2022-09-30 | -$2.05 10-Q · filed 2023-11-14 | -$2.04 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$2.82 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$3.64 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||||
| 2022-06-30 | -$1.19 derived: net income ÷ weighted average shares · filed 2023-09-27 | -$1.96 derived: net income ÷ weighted average shares · filed 2023-09-27 | -$2.79 derived: net income ÷ weighted average shares · filed 2023-09-27 | -$5.78 10-K · filed 2023-09-27 | ||||
| 2022-03-31 | -$1.42 10-Q · filed 2023-05-15 | -$0.06 10-Q · filed 2022-05-12 | -$1.60 derived: net income ÷ weighted average shares · filed 2023-05-19 | -$3.82 10-Q · filed 2023-05-15 | -$0.15 10-Q · filed 2022-05-12 | $0.15 derived: net income ÷ weighted average shares · filed 2023-05-19 | ||
| 2021-12-31 | -$1.37 10-Q/A · filed 2023-05-19 | -$2.40 10-Q/A · filed 2023-05-19 | $0.07 derived: net income ÷ weighted average shares · filed 2023-05-19 | $0.27 derived: net income ÷ weighted average shares · filed 2023-05-19 | ||||
| 2021-09-30 | -$1.03 10-Q · filed 2022-11-14 | $0.02 derived: net income ÷ weighted average shares · filed 2022-11-14 | $0.13 derived: net income ÷ weighted average shares · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.00 derived: net income ÷ weighted average shares · filed 2022-10-11 | $0.05 derived: net income ÷ weighted average shares · filed 2022-10-11 | -$3.00 10-K · filed 2022-10-11 | |||||
| 2021-03-31 | -$0.04 10-Q · filed 2022-05-12 | -$0.12 10-Q · filed 2022-05-12 | ||||||
| 2014-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2016-02-22 | -$0.04 derived: net income ÷ weighted average shares · filed 2016-02-22 | ||||||
| 2014-09-30 | -$0.02 10-Q · filed 2014-11-14 | |||||||
| 2013-12-31 | -$0.03 derived: net income ÷ weighted average shares · filed 2015-02-24 | -$0.02 derived: net income ÷ weighted average shares · filed 2015-02-24 | ||||||
| 2013-09-30 | $0.01 10-Q · filed 2014-11-14 | |||||||
| 2012-09-30 | -$0.04 10-Q · filed 2013-11-14 | |||||||
| 2011-09-30 | $0.01 10-Q · filed 2012-11-14 | |||||||
| 2010-09-30 | -$0.10 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |